Cargando…

The Role of Sphingolipids Metabolism in Cancer Drug Resistance

Drug resistance continues to be one of the major challenges to cure cancer. As research in this field evolves, it has been proposed that numerous bioactive molecules might be involved in the resistance of cancer cells to certain chemotherapeutics. One well-known group of lipids that play a major rol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bataller, Marina, Sánchez-García, Almudena, Garcia-Mayea, Yoelsis, Mir, Cristina, Rodriguez, Isabel, LLeonart, Matilde Esther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733468/ https://www.ncbi.nlm.nih.gov/pubmed/35004331 http://dx.doi.org/10.3389/fonc.2021.807636

Ejemplares similares

Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021)

Autophagy Takes Center Stage as a Possible Cancer Hallmark
por: Alvarez-Meythaler, Jose G., et al.
Publicado: (2020)

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022)

Editorial: Sphingolipid metabolism and cancer
por: Ivanova, Margarita M., et al.
Publicado: (2022)

Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals
por: Feliciano, Andrea, et al.
Publicado: (2020)

Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
por: Benavente, Sergi, et al.
Publicado: (2020)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
por: Kondoh, Hiroshi, et al.
Publicado: (2021)

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2020)

Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
por: Petrusca, Daniela N., et al.
Publicado: (2022)

miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer
por: Feliciano, Andrea, et al.
Publicado: (2017)

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
por: Li, Run-Ze, et al.
Publicado: (2022)

Regulation of PP2A by Sphingolipid Metabolism and Signaling
por: Oaks, Joshua, et al.
Publicado: (2015)

Sphingolipid metabolism and drug resistance in ovarian cancer
por: Kreitzburg, Kelly M., et al.
Publicado: (2018)

Antineoplastic Agents Targeting Sphingolipid Pathways
por: Kroll, Alexander, et al.
Publicado: (2020)

The Role of Sphingolipid Metabolism in Bone Remodeling
por: Qi, Tang, et al.
Publicado: (2021)

Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment
por: Matamala Montoya, María, et al.
Publicado: (2023)

Tumor Profiling at the Service of Cancer Therapy
por: Fernandez-Rozadilla, Ceres, et al.
Publicado: (2021)

Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies
por: Kitatani, Kazuyuki, et al.
Publicado: (2015)

New Insights into the Role of Sphingolipid Metabolism in Melanoma
por: Carrié, Lorry, et al.
Publicado: (2020)

Role of Ceramidases in Sphingolipid Metabolism and Human Diseases
por: Parveen, Farzana, et al.
Publicado: (2019)

The Role of Sphingolipids in Cancer Immunotherapy
por: Giussani, Paola, et al.
Publicado: (2021)

Sphingolipids: Key Regulators of Apoptosis and Pivotal Players in Cancer Drug Resistance
por: Giussani, Paola, et al.
Publicado: (2014)

Sphingolipid metabolism in brain insulin resistance and neurological diseases
por: Mei, Meng, et al.
Publicado: (2023)

Otologic, audiometric and speech findings in patients undergoing surgery for cleft palate
por: Garcia-Vaquero, Cristina, et al.
Publicado: (2018)

Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC
por: Indorato, Rose-Laure, et al.
Publicado: (2022)

Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
por: Merrill, A H, et al.
Publicado: (2001)

The Influence of Metabolism on Drug Response in Cancer
por: Zaal, Esther A., et al.
Publicado: (2018)

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
por: Quinville, Brianna M., et al.
Publicado: (2021)

Computational modeling of sphingolipid metabolism
por: Wronowska, Weronika, et al.
Publicado: (2015)

Autophagy in the light of sphingolipid metabolism
por: Harvald, Eva Bang, et al.
Publicado: (2015)

Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)

Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)

Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis
por: Kilbey, A., et al.
Publicado: (2017)

Metabolism, Physiological Role, and Clinical Implications of Sphingolipids in Gastrointestinal Tract
por: Kurek, Krzysztof, et al.
Publicado: (2013)

The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response
por: Corsetto, Paola Antonia, et al.
Publicado: (2023)

Relationship between metabolic reprogramming and drug resistance in breast cancer
por: Lv, Linlin, et al.
Publicado: (2022)

The Role of Circular RNAs in the Drug Resistance of Cancers
por: Liu, Xin-Yuan, et al.
Publicado: (2022)

Role of DNA Methylation in the Resistance to Therapy in Solid Tumors
por: Romero-Garcia, Susana, et al.
Publicado: (2020)

Sphingolipid Metabolism and Obesity-Induced Inflammation
por: Kang, Se-Chan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_040apt4a3hrujip91iap8gv89d